Please login to the form below

Not currently logged in
Email:
Password:

European biotech

This page shows the latest European biotech news and features for those working in and with pharma, biotech and healthcare.

New leader at Medivir after setbacks

New leader at Medivir after setbacks

Shares in Swedish biotech Medivir were sliding this morning on the sudden departure of chief executive Christine Lind, to be replaced by board member Uli Hacksell. ... Hacksell – who is described in a statement as ‘acting’CEO – will be the fourth

Latest news

More from news
Approximately 7 fully matching, plus 36 partially matching documents found.

Latest Intelligence

  • European venture funding for the life science sector European venture funding for the life science sector

    Capital markets infrastructure is a barrier. European biotech companies continue to find it hard to raise public money in Europe. ... Pockets of success on Euronext mask the fact that leading European venture groups primarily look to the Nasdaq, at least

  • European sites European sites

    European sites. What makes a country in Europe attractive to life science companies? ... Key findings. In total there are roughly 11, 000 life science companies (biotech, pharma, medtech) across 14 European countries and in Israel.

  • Pharma deals in March 2015 Pharma deals in March 2015

    One of Bavarian Nordic's sites is in Martinsried, the biotech cluster near Munich. ... The Morphosys story highlights the uncertainty of funding for European biotech companies.

  • Pharma deals during December 2012 Pharma deals during December 2012

    European biotech also active. Not all the drug discovery action is in Texas or California, as Evotec (based in Germany) has ably demonstrated this year. ... Another deal involving European biotech companies is the acquisition of the Austrian company

  • Interview with Andrea Rappagliosi, EuropaBio Interview with Andrea Rappagliosi, EuropaBio

    The current financial crisis exacerbates the task. I think that in the wider context of the pharmaceutical industry, the European biotech industry can definitely play a role in boosting investment in ... From a biotech perspective, the proposed single

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

  • Apeiron bolsters management board Apeiron bolsters management board

    With more than 25 years’experience in initial public offerings, mergers and acquisitions, as well as licensing and financial transactions in the chemical, biotech and pharma industries, Llewellyn-Davies most recently ... He said: “Apeiron is

  • Novimmune expands senior management team Novimmune expands senior management team

    Novimmune expands senior management team. Dr Sven Zimmerman and Mylène Fleurant join the Swiss biotech. ... Prior to this, Dr Zimmerman was a European biotech analyst at UBS Investment Bank.

  • MRC Technology appoints director of technology transfer MRC Technology appoints director of technology transfer

    Farquharson is additionally appointed to the EU Commission's Expert Group, advising on the European Biotech Directive's impact on patent law and R&D activities.

  • Creabilis names Catherine Moukheibir as chairman of the board Creabilis names Catherine Moukheibir as chairman of the board

    After an initial career in strategy consulting and investment banking, she held a number of senior management role at European biotech firms including CFO at Movetis, non-executive board member at

  • Zealand adds two observers to board of directors Zealand adds two observers to board of directors

    Catherine Moukheibir has held senior management positions in several European biotech companies after an initial career in strategy consulting and investment banking. ... board as we prepare for the next steps in Zealand's growth strategy as a maturing

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...
Geoff
Cancer care – the power of new technologies
With patient numbers set to soar, how can we make a difference?...
image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...

Infographics